Agendia’s landmark FLEX Study reaches a major enrollment milestone, accelerating real-world insights to advance more personalized breast cancer care Agendia®, Inc., a leader in precision oncology for ...

Peer-reviewed data from nearly 30,000 real-world treatments reinforce the role of Nerivio®, a drug-free REN wearable, as an alternative for veterans managing this complex, often service-related ...

Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a biotechnology company commercializing and ...

The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have released a new guideline outlining the steps involved for EU stakeholders, including national competent authorities, ...

AUCKLAND, New Zealand, May 1, 2025 /PRNewswire/ -- Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed ...

Real-world evidence helps pharmaceutical companies and payers communicate more effectively. In this Q&A, Cate Lockhart, PharmD, PhD, chief science officer of the Academy of Managed Care Pharmacy (AMCP ...

In the medical research field, there is one thing that there is no shortage of: data. Data from medical and pharmacy claims, provider data, as well as remittance, eligibility, EHR, and mortality data, ...

DexCom, Inc. DXCM recently announced that results from its CONNECT randomized controlled trial have been published in The New England Journal of Medicine. The study evaluated the benefits of its ...

Suntory’s Institute for Science of Life is conducting a series of real-world evidence studies on its nutraceutical products as part of its new product development strategy. Known as the Wellness Life ...

Agendia®, Inc., a leader in precision oncology for breast cancer, today announced that more than 25,000 patients have now been enrolled in its flagship FLEX Study ( NCT03053193), marking a major ...